GB2203831A — Diagnosis of malignant tumours by fluorescence
Assigned to Academy of Applied Science Inc · Expires 1988-10-26 · 38y expired
What this patent protects
In a non-invasive apparatus for the diagnosis of malignant tumours by intrinsic fluorescence UV light from a source 1 is transmitted by quartz optic fibres 2 to the surface of the living tissue 3, stimulating its intrinsic fluorescence which is transmitted by ordinary optic fibre…
USPTO Abstract
In a non-invasive apparatus for the diagnosis of malignant tumours by intrinsic fluorescence UV light from a source 1 is transmitted by quartz optic fibres 2 to the surface of the living tissue 3, stimulating its intrinsic fluorescence which is transmitted by ordinary optic fibres 4 for signal processing and subsequent display of the intrinsic fluorescence spectrum by graphical means. The presence of the characteristic wave peak in the graph corresponding to evidence of malignancy permits appropriate diagnosis. The colour of the intrinsic fluorescence of the living tissue which determines the presence or absence of malignancy, may also be made with the naked eye. The apparatus may be used clinically to diagnose body surface malignant tumours, as well as those in body cavities within the reach of the optic fibres. <IMAGE>
Drugs covered by this patent
- Spy Agent Green Kit (INDOCYANINE GREEN) · Renew Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.